ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
Femke A I Ehlers, Nicky A Beelen, Michel van Gelder , Tom M J Evers, Marjolein L Smidt, Loes F S Kooreman, Gerard M J Bos, Lotte Wieten